Viewing Study NCT05641532


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-02-27 @ 4:05 PM
Study NCT ID: NCT05641532
Status: COMPLETED
Last Update Posted: 2023-08-16
First Post: 2022-11-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Physical Activity in Persons Newly Diagnosed With Multiple Sclerosis
Sponsor: University of Alabama at Birmingham
Organization:

Study Overview

Official Title: Physical Activity Intervention for Persons Newly Diagnosed With Multiple Sclerosis
Status: COMPLETED
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This single group pre-post pilot intervention will examine the feasibility and initial effect of a 12-week behavioral intervention, based on the Behavior Change Wheel and Capability-Opportunity-Motivation-Behavior (COM-B) model and remotely delivered through electronic newsletters and online one-on-one video conferencing, for promoting physical activity and secondarily reducing fatigue and quality of life in persons newly diagnosed with MS (diagnosed with MS within the past 2 years). The investigators hypothesize the proposed 12-week intervention will be feasible based on process, resource, management, and scientific outcomes. The investigators further hypothesize that individuals who receive the 12-week intervention will demonstrate an increase in physical activity behavior, particularly daily step counts, and reduce fatigue.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: